A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

समान संसाधन

• Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes
  द्वारा: Seymour, John F., और अन्य
  प्रकाशित: (2010)
• Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine
  द्वारा: Santini, Valeria, और अन्य
  प्रकाशित: (2010)
• The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update
  द्वारा: Silverman, LR, और अन्य
  प्रकाशित: (2008)
• Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic Syndromes
  द्वारा: Silverman, Lewis R., और अन्य
  प्रकाशित: (2011)
• Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
  द्वारा: Fenaux, Pierre, और अन्य
  प्रकाशित: (2009)